---
title: "Vertex Pharmaceuticals"
date: "2024-12-09T09:09:24+00:00"
url: "https://aisdr.com/inc-5000-companies-ai-prospecting/vertex-pharmaceuticals/"
---

# Vertex Pharmaceuticals

[Home](https://aisdr.com/) > [Inc 5000 AI Prospecting Database](https://aisdr.com/ai-prospecting-inc-5000-companies/) > Vertex Pharmaceuticals

 Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.

 ![laptop](/wp-content/themes/aisdr2/assets/images/programatic-hero-screen.svg) ![](https://aisdr.com/wp-content/uploads/2024/12/vrtx.com_.png)

## Company data:

Company size:

  **6100 employees**

Website URL:

 [https://www.vrtx.com](https://www.vrtx.com)

Industry

 **Biotechnology**

Headquarters:

 **Boston, Massachusetts, USA**

Investment round:

 **Publicly Traded (NASDAQ: VRTX)**

ARR:

  **$9 billion**

Social media profiles

 [            ](http://www.linkedin.com/company/vertex-pharmaceuticals) [           ](http://www.twitter.com/vertexpharma) [    ](https://www.instagram.com/vertexpharma) [           ](https://www.facebook.com/VertexPharmaceuticals)

  ### Key stakeholders

These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates

Reshma Kewalramani

President & Chief Executive Officer

 [            ](https://www.linkedin.com/in/ACoAAASVMyYBeXqkKHYv7jEkX5fGNaQ4W3iwsXw)

Stephanie Franklin

Senior VP & Chief Human Resources Officer

 [            ](https://www.linkedin.com/in/ACoAAAA0dzEBkykxk1BaeDYgTucitt9Xh33lxpA)

Kristen Ambrose

Senior Vice President, Chief Accounting Officer

 [            ](https://www.linkedin.com/in/kristenambrose)

  ### Latest news about Vertex Pharmaceuticals

Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates

Vertex Pharmaceuticals will announce its first quarter 2025 financial results on May 5, 2025, after market close, with a conference call at 4:30 PM ET. Analysts estimate Q1 2025 non-GAAP EPS of $3.75, reflecting higher R&D spending and costs from the Alpine Immune Sciences acquisition\[3\]\[5\].

Vertex researcher Paul Negulescu, Ph.D., has been awarded the 2025 Canada Gairdner International Award for pioneering research into the cellular and molecular mechanisms of cystic fibrosis\[4\].

Vertex Pharmaceuticals has announced the UK MHRA approval of ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor), a once-daily next-in-class CFTR modulator for the treatment of cystic fibrosis, as of March 7, 2025\[2\].

  ### Open job positions at Vertex Pharmaceuticals

This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

Medical Affairs Digital Program Director

Director, HCP Marketing, US Kidney - Pove

Director, Patient Marketing, US Kidney - Pove

##  AI sales outreach emails you can send to Vertex Pharmaceuticals

See samples of how AiSDR handles your outbound emails with the prospecting data available

 ![](https://aisdr.com/wp-content/uploads/2024/11/Mail-2-1.png)      Fwd: quick question about growth   Taylor Jakes <[\[email protected\]](/cdn-cgi/l/email-protection)> to AiSDR   Hi Reshma, Your team's recent breakthrough in cystic fibrosis treatment with ALYFTREK is remarkable. Building and scaling a biotech company while maintaining rapid innovation isn't easy - I know this firsthand. I have an offer for you: share your biggest sales challenge right now, and we'll diagnose in a 15-minute call if AI can help your team respond faster to market opportunities and accelerate growth. Are you open to exploring this?

      Fwd: streamline sales with ai   Sam Gordon <[\[email protected\]](/cdn-cgi/l/email-protection)> to AiSDR   Hi Stephanie, Impressive seeing Vertex's breakthroughs in CF treatments alongside your rapid team growth. Managing talent development and recruitment at this scale while maintaining R&D momentum is quite a challenge. I have an offer for you: share your biggest sales operations challenge right now, and we'll diagnose in a 15-minute call if AI can help streamline your commercial teams' outreach and response times. Would this be relevant for you?

 ![](https://aisdr.com/wp-content/uploads/2024/11/Mail-3-1.png)      Fwd: scaling global sales efficiently   Alex Cross <[\[email protected\]](/cdn-cgi/l/email-protection)> to AiSDR   Hi Kristen, Congrats on the recent ALYFTREK approval in the UK. Managing global sales expansion while keeping up with groundbreaking R&D milestones like this requires seamless coordination between teams. I have an offer for you: share your biggest sales challenge right now, and we'll diagnose in a 15-minute call if AI can help your team scale commercial operations more efficiently. Would you be interested in exploring this?

 ##  See how AiSDR will sell to you.

 Share your info and get the first-hand experience

 TRY AISDR

 Start scaling your sales outreach today!